Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations
Top Cited Papers
Open Access
- 11 February 2025
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (7)
Abstract
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a major cause of liver disease worldwide, and our understanding of its pathogenesis continues to evolve. MASLD progresses from steatosis to steatohepatitis, fibrosis, and cirrhosis, and this Review explores how the gut microbiome and their metabolites contribute to MASLD pathogenesis. We explore the complexity and importance of the intestinal barrier function and how disruptions of the intestinal barrier and dysbiosis work in concert to promote the onset and progression of MASLD. The Review focuses on specific bacterial, viral, and fungal communities that impact the trajectory of MASLD and how specific metabolites (including ethanol, bile acids, short chain fatty acids, and other metabolites) contribute to disease pathogenesis. Finally, we underscore how knowledge of the interaction between gut microbes and the intestinal barrier may be leveraged for MASLD microbial-based therapeutics. Here, we include a discussion of the therapeutic potential of prebiotics, probiotics, postbiotics, and microbial-derived metabolites.Keywords
This publication has 139 references indexed in Scilit:
- Sodium in relation with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studiesFood Science & Nutrition, 2022
- The Commensal Microbe V eillonella as a Marker for Response to an FGF19 Analog in NASHHepatology, 2020
- Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South TexasHepatology Communications, 2020
- Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLDHepatology, 2019
- Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol‐Inducible Cytochrome P450‐2E1–Mediated Oxidative and Nitrative StressHepatology, 2019
- Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy SubjectsMolecular Nutrition & Food Research, 2019
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in miceHepatology, 2013
- Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASHHepatology, 2012
- Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†Hepatology, 2009